PeptideStack
5.2kquestions
20kanswers
220users

How many freeze-thaw cycles will orforglipron at 2 mg/mL tolerate?

Asked 17 Dec 2024Modified 18 months agoViewed 27k times
35

What I am working with: orforglipron · 2 mg/mL.

This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory.

What I have done so far is read the label documentation where it exists and the two pharmacopoeial monographs that are publicly available, which cover the licensed presentation and say nothing about a research one.

What would you do, and what would you check afterwards?

freeze-thaw
freeze-thaw

What repeated freezing does to a peptide in solution: ice-crystal shear at the growing front, freeze-concentration of solutes, pH shifts as buffer…

57 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
orforglipron
orforglipron

A non-peptide, orally bioavailable small-molecule GLP-1 receptor agonist studied in the ATTAIN programme. It is not a peptide, which changes…

219 questions
shareeditfollowflag
AV
askedanders_vestby8.5k1617 Dec 2024
6What temperature, and for how long? Both are needed before anyone can say anything useful. – tamsin_wray 6 months ago
7Do you know the residual moisture? It predicts this better than any date does. – Dr_Fatima_Belkacem 7 months ago
add a comment

4 Answers

Accepted answer first, then by votes
119

Accepted answer

Nobody has published a cycle count, and at 2 mg/mL the concentration tells you what a wrong guess costs: a 0.1 mL aliquot holds 0.2 mg and every microlitre is 2 µg. Damage from freezing is not gradual attrition — it is concentrated at the phase transitions, where ice excludes solute and the unfrozen fraction climbs well above 2 mg/mL for as long as the transition lasts. Two slow cycles can therefore do more than four fast ones, which is why a cycle count is the wrong unit in the first place. The way to make the number one is to make it one: split at reconstitution into single-draw aliquots, label each with 2 mg/mL and the date, and never thaw a container you will refreeze.

Start with how many cycles are actually planned, because one or two are immaterial and ten are not.

Buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.

Reported and extrapolated stability by condition

StateConditionUsable windowBasis
Lyophilised solid−20 °C, sealed, dry24–36 monthsSupplier guidance
Lyophilised solid2–8 °C, sealed12–24 monthsSupplier guidance
Lyophilised solid25 °C, sealed4–8 weeksExtrapolated (Arrhenius)
Lyophilised solid40 °C, sealed1–2 weeksExtrapolated
Solution, preserved2–8 °C28 daysUSP microbiological convention
Solution, preserved25 °C3–7 daysExtrapolated
Solution, unpreserved2–8 °C24 hoursUSP microbiological convention

Windows for the solid state are chemical; windows for solution are microbiological and usually shorter than the chemical limit.

Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.

Selective crystallisation of sodium phosphate buffer components producing large pH shifts on freezing is a classical result in the lyophilisation literature.

Count cycles, not degrees. The cycle is the damaging event.

shareimprove this answerflag
DL
answered · acceptedDr_Otto_Lindqvist72k5822 Dec 2024
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
46

The short version: aliquot before freezing, thaw slowly, never refreeze a thawed aliquot, and count your cycles.

During freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.

The mitigation is aliquoting. Divide the reconstituted solution into single-use volumes before the first freeze, and each aliquot then experiences exactly one cycle.

Dry powder tolerates cycles far better than solution does.

shareimprove this answerflag
KS
answeredk_szabo27k272 Jan 2025
6This should be linked from the help pages. – fill_volume 5 months ago
add a comment
37

This is one of the few handling questions with a genuinely quantitative literature behind it.

Thaw slowly at room temperature or in the refrigerator rather than in warm water. Rapid warming creates local thermal and concentration gradients that promote aggregation.

Never refreeze a thawed aliquot. The whole point of aliquoting is that the aliquot is single-use, and refreezing it discards the benefit.

Aliquoting to eliminate repeated cycles is standard laboratory practice for exactly this reason.

Thaw slowly and never refreeze an aliquot.

shareimprove this answerflag
HP
answeredh_pergande71k15814 Jan 2025
5Two lots stored differently, reassayed at a year — the difference was smaller than I expected. – m_haraldsen 8 months ago
6Aliquoting before the first freeze is the advice I wish I had read two years ago. – sian_llewellyn 10 months ago
add a comment
29

The underlying point is that thawing at room temperature rather than in warm water reduces the interfacial stress.

A dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.

Aliquot before the first freeze. That is the whole answer.

shareimprove this answerflag
LC
answeredlyoph_cake78k26725 Jan 2025
2Same experience here, different supplier. – tabular_nums 22 days ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.